From these results, we conclude that the limited effect of enforcing or knocking-down PTEN expression suggests that other, co-occurring genetic variables, perhaps including mutations in other PI3K/AKT pathway elements as have been previously reported in patient T-ALL samples[12], likely function in combination with PTEN loss to confer IGF independence. The gene discussed is IGF1; the disease is acute lymphoblastic leukemia.